Thrombotic events remain low with use of coagulation factor VIIa recombinant - Healio

Thrombotic events remain low with use of coagulation factor VIIa recombinant  Healio

The rate of thrombotic events among patients treated with coagulation factor VIIa recombinant within its licensed indications continues to be low and has ...